Antiarrhythmic Medications

Antiarrhythmic drug therapy is a treatment option for many patients with cardiac tachyarrhythmias. Table 1 summarizes the common medications used for the treatment of cardiac arrhythmias.

Table 1. Commons Medications Used in the Treatment of Cardiac Tachyarrhythmias

Class of Medication
Examples
Common Side Effects*
Digitalis Glycosides
Digoxin
None at therapeutic levels
Beta-Adrenergic Blocking Drugs
Atenolol, Propranolol,
Metoprolol
Fatigue, Lethargy
Calcium Channel Blocking Drugs
Verapamil, Diltiazem
Constipation, Fatigue
Class IA Antiarrhythmic Drugs
Quinidine, Procainamide, Disopyramide
Variable. Rarely, may cause arrhythmias.
Class IC Antiarrhythmic Drugs
Flecainide, Propafenone
Variable. Rarely, may cause arrhythmias.
Class III Antiarrhythmic Drugs
Sotalol, Amiodarone, Dofetilide
Variable. Amiodarone may cause liver, thyroid, or lung problems. Rarely, may cause arrhythmias.
*In all cases, side effects cannot be predicted and are dependent upon individual patient variation.

Calcium blockers and beta-adrenergic blockers are the most common medications used for patients with AV nodal reentrant tachycardia, AV reciprocating tachycardia, and atrial tachycardia because they have mild side effects and may be very effective. Patients with atrial flutter and atrial fibrillation often require treatment with class I, II, or III antiarrhythmic drugs for best control. Patients with potentially life-threatening ventricular tachyarrhythmias generally are treated with implantable cardioverter-defibrillators (ICD), although amiodarone or sotalol are often used in conjunction with the ICD. However, patients with atypical monomorphic ventricular tachycardia (and structurally normal hearts) may be effectively and safely treated with these drugs.

Drug efficacy, however, is highly individualized, with some patients responding very well to these medications, while other patients may find these medications completely ineffective. It is rare that a medication is either 100% effective or 100% ineffective, with most providing partial improvement in the frequency, severity, and duration of arrhythmia episodes. In addition, drug therapy of these arrhythmias is a trial and error proposition; it is not possible to determine ahead of time which medication will work best in a particular patient. The critical feature of drug therapy is that it does not cure the tachycardia; at best it only can suppress the tachyarrhythmia if the medication is taken on a regular basis. Because an oral medication can take an hour or more to reach significant levels in your blood after swallowing the pill or tablet, taking the medication only at the time of onset of the tachycardia is rarely effective in immediately terminating the arrhythmia.